News and updates
Effective treatment of aging patients with hematological diseases discussed duri...
The progress in the field of aging and the optimal and rational approaches of "fit" and "unfit" older patients with malignant hemopathies was the focus of the three-day EHA-SWG Scientific Meeting...
EHA and Polish Society’s third tutorial together focused on myeloid and lymphoid...
Seventy-five participants from Europe and the Middle East learned about the advances in biology, genetic characteristics, diagnostic approaches and therapy of leukemias during the EHA-PTHiT Hematology Tutorial on Myeloid and...
Second EHA-SAH tutorial in Argentina, another success
Hematologists from South America and mainland US gathered in Argentina on September 14-15 for brain-stretching exercises on the topics of lymphoid malignancies and plasma cell dyscrasias.
Nobel prize goes to immunotherapy researchers
October 1, Sweden - Cancer kills millions of people every year and is one of humanity’s greatest health challenges.
EHA European Hematology Exam 2018 Report
The second European Hematology Exam took place on Wednesday, June 13 during the 23rd Congress of EHA in Stockholm, Sweden, and a parallel session was held in Bern, Switzerland.
Major changes needed for patients to benefit from precision medicine
Precision medicine approaches the treatment of a disease via an individual’s genes, environment, and lifestyle. It will allow the accurate prediction of which treatment and prevention strategies for a particular...
Tutorial on thalassemia focused on best treatment
Almost 90 delegates from Shiraz and other cities in Iran learned how to identify the best treatment for each thalassemia patient at the EHA-SHRC Hematology Tutorial on Thalassemia on May...
Tutorial on acute leukemia held in Istanbul
EHA and the Turkish Society of Hematology (TSH) partnered for the seventh time to organize a tutorial.
Hans Erik Johnsen 1948-2018
On May 17, 2018, just after his 70th birthday, Hans Erik Johnsen passed away. Hans Johnsen was Professor of Clinical Hematology at the Department of Hematology at Aalborg University in Denmark.
The 3rd EHA-ISHBT Hematology Tutorial on Lymphoproliferative and Plasma Cell Dis...
The 3rd EHA-ISHBT Hematology Tutorial on Lymphoproliferative and Plasma Cell Disorders was held on February 16-18 in Lucknow, India, and chaired by Dr AK Tripathi (King George’s Medical University, Lucknow, India) and Prof G Gaidano (University of Eastern Piedmont, Novara, Italy).
All-encompassing meeting on ALL highly rated by participants
Almost 200 delegates from over 30 countries benefitted from stimulating and excellent discussions about Acute Lymphoblastic Leukemia (ALL) at the EHA-SWG Scientific Meeting on New Molecular Insights and Innovative Management...
Dutch scientists propose algorithm to keep drugs affordable and accessible
The paper, titled ‘Sustainability and affordability of cancer drugs: a novel pricing model’ and written by Professor Carin Uyl-de Groot and Professor Bob Lӧwenberg from Erasmus University Rotterdam in the Netherlands, proposes an algorithm that should be used to determine innovative drug prices with ‘a maximum level of transparency’.
Integrated Diagnosis Strategies in Oncohematology for the Management of Cytopeni...
111 hematologists from 31 countries met in Barcelona for a three-day scientific meeting on Integrated Diagnosis Strategies in Oncohematology for the Management of Cytopenias and Leukocytosis.
FP9 recommendations BioMed Alliance
With preparations under way for the EU’s next Framework Programme for Research and Innovation (FP9), the BioMed Alliance has called for more robust EU support for health research. In a recent position paper, the alliance makes the case for increased funding for basic, clinical and translational research and for the development of a long-term vision and strategy involving the creation of a European Council for Health Research.
Two genes cooperate to trigger leukemia development
Congratulations to the international group of researchers led by HemaSphere Editor-in-Chief Prof. Jan Cools of the VIB-KU Leuven Center for Cancer Biology who have made a breakthrough in understanding the development of acute lymphoblastic leukemia, an aggressive cancer of the blood.